首页> 外文期刊>Radiation oncology >Seed migration after transperineal interstitial prostate brachytherapy by using loose seeds: Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS) multi-institutional cohort study
【24h】

Seed migration after transperineal interstitial prostate brachytherapy by using loose seeds: Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS) multi-institutional cohort study

机译:通过使用松散种子进行细胞体间质前列腺前列腺术后的种子迁移:日本前列腺癌结果研究永久性碘-125种子植入(J-POPS)多机构队列研究

获取原文
           

摘要

The incidence and associated factors of loose seed migration were investigated in cohort 1 of the Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS). The study subjects were 2160 patients, consisting of 1641 patients who underwent permanent iodine-125 seed implantation (PI) and 519 patients who underwent PI combined with external beam radiation therapy (PI?+?EBRT). The presence or absence of seed migration to the chest and abdominal/pelvic region was determined. Seed migration was observed in 22.7?% of PI group patients and 18.1?% of PI?+?EBRT group patients (p?=?0.0276). Migration to the lungs and abdominal/pelvic region was observed in 14.6?% and 11.1?% of the patients in the PI group, and 11.2?% and 8.5?% of the patients in the PI?+?EBRT group, respectively. In the PI group, the number of implanted seeds was associated with the seed migration incidence. Neither the PI nor the PI?+?EBRT group showed any difference in the volume of the prostate receiving 100?% of the prescribed dose (V100 [%]) or the minimal dose received by 90?% of the prostate volume (D90 [Gy]) between the patients with and without seed migration. This prospective cohort study investigating the largest number of past cases showed no difference in D90 (Gy) or V100 (%) between seed migration or the absence thereof in both the PI group and PI?+?EBRT group. ClinicalTrials.gov: NCT00534196
机译:在碘-125种子植入(J-POPs)的日本前列腺癌结果研究中,研究了宽松种子迁移的发病率和相关因素(J-POPS)。该研究受试者是2160名患者,由1641名接受永久性碘-125种子植入(PI)和519名患者的患者组成,接受PI与外梁放射治疗(PI?+ eBRT)。确定种子迁移的存在或不存在于胸部和腹部/盆腔区域。在22.7%的PI组患者中观察到种子迁移,18.1%的pi?+ +α蛋白(p?= 0.0276)。在PI组中的14.6℃和11.1倍的患者中迁移到肺部和腹腔/盆腔区域,分别在PIα+ + +欧洲血症组中的11.2℃和8.5倍的患者中迁移。在PI组中,植入种子的数量与种子迁移发病率有关。 pi和pi?+ + + + + + + + +?eBRT组在接受预定剂量(V100 [%])的前列腺的体积中的任何差异,或者在前列腺体积的90μm%(D90 [ gy])在没有种子迁移的患者之间。该预期队列研究调查最大数量的过去案例在种子迁移或PIα+ +α+ + + +α+ + + + + + + + + +α+ + + + + + + + + +ε中没有差异。 ClinicalTrials.gov:NCT00534196.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号